CTCAE RápidoAdverse event grades · CTCAE v6.0
Código Onco

INR increased

Investigations
  1. G1>1.2 - 1.5; >1 - 1.5 x baseline if on anticoagulation; monitoring only indicated
  2. G2>1.5 - 2.5; >1.5 - 2.5 x baseline if on anticoagulation; dose adjustment indicated
  3. G3>2.5; >2.5 x baseline if on anticoagulation; bleeding
  4. G4Not applicable
  5. G5Not applicable
Definition and note

DefinitionA finding based on laboratory test results that indicate an increase in the ratio of the patient's prothrombin time (PT) to a control sample in the blood.

MedDRA code (LLT): 10022402 · CTCAE v6.0 (NCI), original English text.

Other events in Investigations

Activated partial thromboplastin time prolongedAlanine aminotransferase increasedAlkaline phosphatase increasedAspartate aminotransferase increasedBlood antidiuretic hormone abnormalBlood bicarbonate decreasedBlood bilirubin increasedBlood corticotrophin decreasedBlood gonadotrophin abnormalBlood lactate dehydrogenase increasedBlood prolactin abnormalCarbon monoxide diffusing capacity decreasedCD4 lymphocytes decreasedCholesterol highCreatinine clearance decreasedCreatinine increasedElectrocardiogram QT corrected interval prolongedFibrinogen decreasedForced expiratory volume decreasedGGT increasedGrowth hormone abnormalHaptoglobin decreasedHDL decreasedHemoglobin increased

Search another event

From the same authorCódigo OncoCódigo Onco (in Portuguese): Brazilian public health system (SUS) codes for systemic cancer treatment.